Wearable device and non-invasive method for performing tunable multimodal therapy on a subject

A wearable device using an AC-driven MOS capacitor provides tunable multimodal therapy, addressing the limitations of existing treatments by combining electrotherapy and phototherapy in a flexible, energy-efficient format for continuous home use, enhancing therapeutic outcomes and reducing healthcare burden.

WO2026235633A1PCT designated stage Publication Date: 2026-11-12AGENCY FOR SCI TECH & RES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/SG2026/050289
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-07
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Current treatments for chronic diseases, such as electrotherapy and phototherapy, are inconvenient, costly, and often require hospital visits, lacking portability and flexibility, and do not combine both modalities effectively, leading to suboptimal therapeutic outcomes and increased healthcare burden.

Method used

A wearable device utilizing an AC-driven metal oxide semiconductor (MOS) capacitor with a light-emitting electroluminescence layer and coiled electrodes to provide tunable multimodal therapy, combining electrotherapy and phototherapy, which is flexible, disposable, and energy-efficient, allowing for continuous treatment at home.

Benefits of technology

The wearable device offers a cost-effective, scalable, and comfortable solution for personalized therapy, enhancing wound healing and pain relief by simultaneously applying adjustable electric fields and light wavelengths, reducing reliance on healthcare facilities and improving patient convenience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SG2026050289_12112026_PF_FP_ABST
    Figure SG2026050289_12112026_PF_FP_ABST
Patent Text Reader

Abstract

According to embodiments, a wearable device for performing tunable multimodal therapy on a subject is provided. The wearable device includes a protective layer; and an AC-driven MOS capacitor disposed on the protective layer. The AC-driven MOS capacitor includes a light-emitting electroluminescence layer adapted to generate light with one or more selectable wavelengths upon applying an electric field; a pair of coiled electrodes configured to receive an adjustable AC signal to generate the electric field, the light-emitting electroluminescence layer arranged coplanar with and between the pair of coiled electrodes; a gate layer configured to receive the adjustable AC signal for tuning the one or more selectable wavelengths and / or an energy level of the light; and a dielectric layer arranged between the light-emitting electroluminescence layer and the gate layer. According to further embodiments, a non-invasive method for performing tunable multimodal therapy is also provided.
Need to check novelty before this filing date? Find Prior Art

Description

WEARABLE DEVICE AND NON-INVASIVE METHOD FOR PERFORMING TUNABLE MULTIMODAL THERAPY ON A SUBJECTCross-Reference To Related Application

[0001] This application claims the benefit of priority of Singapore patent application No. 10202501197W, filed 9 May 2025, the content of it being hereby incorporated by reference in its entirety for all purposes.Technical Field

[0002] Various embodiments relate to a wearable device for performing tunable multimodal therapy on a subject and a non-invasive method for performing tunable multimodal therapy on a subject.Background

[0003] The current problem of increasing prevalence of chronic diseases requires longterm and non-invasive treatments. Singapore has the second-highest proportion of people with diabetes among developed nations. These chronic diseases are straining hospital capacities as these facilities are already overwhelmed with patients. Treating chronic diseases in a hospital setting is not only resource-intensive but is also inconvenient for patients who need continuous care. Therefore, there is a critical need to develop innovative therapeutic devices that are safe, non-invasive, and suitable for home use, allowing patients to manage their conditions more comfortably and efficiently at home while alleviating the burden on healthcare facilities.

[0004] However, current solutions for treating chronic hemodynamic diseases and promoting wound healing often rely on conventional methods such as hospital-administered treatments, wound dressings, electrotherapy, and phototherapy. These methods, while effective to some extent, face several challenges. For example, most of the current treatments, such as electrotherapy and phototherapy, require patients to visitmedical facilities, making it inconvenient for individuals with chronic conditions who require long-term, continuous care. This limited accessibility creates a burden on healthcare systems and leads to higher treatment costs. Traditional devices are typically designed to provide either phototherapy or electrotherapy, but not both simultaneously. Such single-modality therapies limit the overall therapeutic effect. Combining both modalities would accelerate wound healing and provide more effective treatment. Current phototherapy devices and / or electrotherapy devices are often bulky and non-portable. Patients may need to remain stationary or make frequent visits to healthcare centers. Existing technologies, especially those used in hospital settings, tend to be costly and difficult to scale for widespread, personal use. In addition, most devices are rigid and lack flexibility since they are not designed to conform to a patient body's natural curves, while limiting their usability for home-based, everyday applications. Many traditional devices, especially those relying on light emitting diodes (LEDs) or other light sources, consume significant amounts of power, generating heat that may be uncomfortable or even harmful to the patient.[0005J Thus, there is a need for a wearable device and / or a non-invasive method for performing tunable multimodal therapy, thereby addressing at least the problems mentioned above.Summary

[0006] According to an embodiment, a wearable device for performing tunable multimodal therapy on a subject is provided. The wearable device includes a protective layer; and an alternative current (AC)-driven metal oxide semiconductor (MOS) capacitor disposed on the protective layer. The AC-driven MOS capacitor includes: a light-emitting electroluminescence layer adapted to generate light with one or more selectable wavelengths upon applying an electric field, a pair of coiled electrodes configured to receive an adjustable AC signal to generate the electric field, the light-emitting electroluminescence layer arranged coplanar with and between the pair of coiled electrodes; a gate layer configured to receive the adjustable AC signal for tuning the one or more selectable wavelengths and / or an energy level of the light generated by the light-emitting electroluminescence layer; and a dielectric layer arranged between the lightemitting electroluminescence layer and the gate layer.

[0007] According to an embodiment, a non-invasive method for performing tunable multimodal therapy on a subject is provided. The non-invasive method includes placing a wearable device on a target skin surface of the subject, wherein the wearable device comprises an AC-driven MOS capacitor; applying an electric field generated by a pair of coiled electrodes of the AC-driven MOS capacitor onto the target skin surface to facilitate skin growth and wound healing; emitting light with one or more selectable wavelengths on the target skin surface to facilitate pain relief and enhanced wound healing, wherein the light is generated by a light-emitting electroluminescence layer of the AC-driven MOS capacitor upon applying the electric field; and tuning, by a gate layer of the AC-driven MOS capacitor, the one or more selectable wavelengths and / or an energy level of the light. The light-emitting electroluminescence layer arranged coplanar with and between the pair of coiled electrodes, a dielectric layer, and the gate layer are arranged to form a stacked configuration of the AC-driven MOS capacitor.Brief Description of the Drawings

[0008] In the drawings, like reference characters generally refer to like parts throughout the different views. The drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention. In the following description, various embodiments of the invention are described with reference to the following drawings, in which:

[0009] FIG. 1A shows a schematic cross-sectional view of a wearable device for performing tunable multimodal therapy on a subject, according to various embodiments.

[0010] FIG. IB shows a flow chart illustrating a non-invasive method for performing tunable multimodal therapy on a subject, according to various embodiments.

[0011] FIG. 2A shows a schematic cross-sectional view illustrating the structure of a wearable multimodal therapy LEC-based patch, according to an example.

[0012] FIG. 2B shows a top view of the wearable multimodal therapy LEC-based patch of FIG. 2A.

[0013] FIG. 3 shows a schematic representation illustrating a finite element analysis simulation of the electric field distribution of the coiled electrodes, according to an example.

[0014] FIG. 4 shows an output light wavelength spectrum with the frequency of 10 kHz, according to an example.

[0015] FIG. 5 shows an output light wavelength spectrum with the frequency of 1 MHz, according to an example.Detailed Description

[0016] The following detailed description refers to the accompanying drawings that show, by way of illustration, specific details, and embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. Other embodiments may be utilized and structural, logical, and electrical changes may be made without departing from the scope of the invention. The various embodiments are not necessarily mutually exclusive, as some embodiments can be combined with one or more other embodiments to form new embodiments.

[0017] Embodiments described in the context of one of the methods or devices are analogously valid for the other methods or devices. Similarly, embodiments described in the context of a method are analogously valid for a device, and vice versa.

[0018] Features that are described in the context of an embodiment may correspondingly be applicable to the same or similar features in the other embodiments. Features that are described in the context of an embodiment may correspondingly be applicable to the other embodiments, even if not explicitly described in these other embodiments. Furthermore, additions and / or combinations and / or alternatives as described for a feature in the context of an embodiment may correspondingly be applicable to the same or similar feature in the other embodiments.

[0019] In the context of various embodiments, the articles “a”, “an” and “the” as used with regard to a feature or element include a reference to one or more of the features or elements.

[0020] In the context of various embodiments, the phrase “at least substantially” may include “exactly” and a reasonable variance

[0021] In the context of various embodiments, the term “about” or “approximately” as applied to a numeric value encompasses the exact value and a reasonable variance.

[0022] As used herein, the term “and / or” includes any and all combinations of one or more of the associated listed items.

[0023] As used herein, the phrase of the form of “at least one of A or B” may include A or B or both A and B. Correspondingly, the phrase of the form of “at least one of A or B or C”, or including further listed items, may include any and all combinations of one or more of the associated listed items.

[0024] As used herein, the expression “configured to” may mean “constructed to” or “arranged to”.

[0025] Various embodiments provide disposable flexible photoelectro-therapeutic skin patches for tuneable multimodal therapy.

[0026] FIG. 1A shows a schematic cross-sectional view of a wearable device 100 for performing tunable multimodal therapy on a subject, according to various embodiments. The wearable device 100 includes a protective layer 102; and an alternative current (AC)-driven metal oxide semiconductor (MOS) capacitor 104 disposed on the protective layer 102, as denoted by a line 114. The AC-driven MOS capacitor 104 includes a light-emitting electroluminescence layer 106 adapted to generate light with one or more selectable wavelengths upon applying an electric field; a pair of coiled electrodes 108a, 108b configured to receive an adjustable AC signal to generate the electric field; a gate layer 112 configured to receive the adjustable AC signal for tuning the one or more selectable wavelengths and / or an energy level of the light generated by the light-emitting electroluminescence layer 106; and a dielectric layer 110 arranged between the lightemitting electroluminescence layer 106 and the gate layer 112, as denoted by line 116 and line 118, respectively. The light-emitting electroluminescence layer 106 is arranged coplanar with and between the pair of coiled electrodes 108a, 108b.

[0027] In the context of various embodiments, the expression “disposed on” may mean coupled to or in contact with. The term “coplanar” refers to being laterally (sideways) along the same plane or at least substantially the same plane.

[0028] The gate layer 112, the dielectric layer 110 and the coplanar arrangement of the light-emitting electroluminescence layer 106 and the pair of coiled electrodes 108a, 108beffectively form a stacked configuration of the AC -driven MOS capacitor. The coplanar arrangement of the light-emitting electroluminescence layer 106 and the pair of coiled electrodes 108a, 108b may be placed towards the top portion of the stacked configuration and when in use, may be facing towards the skin of the subject such that the light emitted from the light-emitting electroluminescence layer 106 reaches the skin in an efficient manner. In one example, for the coplanar arrangement, a surface of the light-emitting electroluminescence layer 106 that is placed facing towards the skin of the subject may be flushed with at least one surface of each coiled electrode 108a, 108b along the same plane. Each of these layers / elements may be flexible.

[0029] In other words, the wearable device 100 includes a wearable multimodal therapy patch based on light emitting capacitor (LEG) technology, operating on the principle of electroluminescence (EL). The wearable device 100 includes flexible organic / inorganic layers that are configured to emit selected light wavelengths, such as red light, near-infrared light, and blue light, when an electric field is applied. The combination of electric field and light provides the dual therapeutic effects of electrotherapy and phototherapy. This LEC-based patch is a flexible, disposable, and non-invasive solution, making it cost-effective for large-scale (mass) manufacturing which is a critical step in making advanced therapies accessible and suitable for home use The patch is capable of being attached to the subject (a patient) without interfering with the patient’s daily routine as it can easily conform to the curves of the patient’s body and is available in a various shapes and sizes. The limitations of current treatments are addressed by offering such a disposable, scalable, energy-efficient, and continuous therapy device, which also helps to reduce the burden and reliance on healthcare facilities for regular treatments, while enabling patients to receive high-quality therapy at home.

[0030] In various embodiments, the light-emitting electroluminescence layer 106 may include an ultrathin layer of low-energy emitting molecules and a host layer of high-energy emitting molecules, the light-emitting electroluminescence layer 106 configured to generate selectable wavelengths including blue, green, red, and near-infrared light under the applied electric field. The ultrathin layer of low-energy emitting molecules may be significantly thinner than the host layer.

[0031] The low-energy emitting molecules may include an inorganic material. For example, the low-energy emitting molecules may include 4,4’-bis(N-carbazolyl)-l,l’-biphenyl; 9, 10-bis(4-(9H-carbazol-9-yl)-2,6-dimethylphenyl)-9, 1 O-diboraanthracene; bis[2-(2-pyridinyl-N)phenyl-C](acetylacetonate)iridium(TIT); thulium; neodymium; erbium; magnesium; copper; copper-silver alloy; cerium; poly [2-methoxy-5-(2’-ethylhexyloxy)-l,4-phenylene vinylene]; poly(N-vinylcarbazole), or a blend of 2-tert-butylphenyl-5-biphenyl- 1 ,3,4-oxadiazol with poly(N-vinylcarbazole).

[0032] The high-energy emitting molecules may include an organic material or an inorganic material. For example, the high-energy emitting molecules may include 4,4'-Bis (N-carbazolyl)-l,l'-biphenyl; zinc sulfide; strontium sulfide; Eu(TTFA)3(phen) where TTFA is thenoyltrifluoroacetone monoanion and phen is 1,10-phenanthroline; or Yb(TPP)acac where TTP is tetraphenylporphyrin.

[0033] The pair of coiled electrodes 108a, 108b may include interdigital coiled electrodes, which advantageously allow for compactness, high sensitivity, and fast response.

[0034] The pair of coiled electrodes 108a, 108b may include gold, platinum, or palladium.

[0035] The pair of coiled electrodes 108a, 108b may provide top coplanar interdigital coiled electrodes (relative to a bottom gate layer 112) for AC-driven and electrical field emitting.

[0036] The gate layer 112 may include silver. In other words, the silver paste layer may serve as the back gate along with the dielectric layer 110 for control signal. In other examples, the gate layer 112 may include gold, aluminum, copper, indium tin oxide, graphene, a conductive polymer, or any combinations thereof.

[0037] In various embodiments, the wearable device 100 may further include a further protective layer, wherein the AC-driven MOS capacitor 104 may be arranged between the protective layer 102 and the further protective layer. For example, each of the protective layer 102 and the further protective layer may include thermoplastic polyurethane. The protective layer 102 may be referred to a lower or underlying protective layer adjacent to the gate layer 112, and the further protective layer may be referred to as an upper protective layer adjacent to the light-emitting electroluminescence layer 106.

[0038] In various embodiments, the wearable device 100 may further include a hydrogel layer disposed over and encapsulating at least part of the light-emittingelectroluminescence layer 106 and the pair of coiled electrodes 108a, 108b. When in use, the hydrogel layer is in direct contact with the skin of the subject, allowing the electric field and the light to penetrate through and onto the skin surface. The hydrogel layer may be configured to deliver one or more therapeutic agents to the subject upon contact with the subject.

[0039] In various embodiments, the wearable device 100 may further include a flexible supporting base coupled to the protective layer 102. For example, the flexible supporting base may include a fabric tape configured to adhere or stick the wearable device 100 to the subject.

[0040] The AC-driven MOS capacitor 104 may be fabricated via film patterning and printing techniques.

[0041] FIG. IB shows a flow chart illustrating a non-invasive method 120 for performing tunable multimodal therapy on a subject, according to various embodiments. As seen in FIG. IB, at Step 122, a wearable device (e.g. 100 of FIG. 1A) is placed on a target skin surface of the subject. The wearable device described in the non-invasive method 120 may include the same or like elements or components as those of the wearable device 100 of FIG. 1A, and as such, the same numerals are assigned and the like elements may be as described in the context of the wearable device 100 of FIG. 1A, and therefore the corresponding descriptions are omitted here. The wearable device 100 includes an AC-driven MOS capacitor 104.

[0042] At Step 124, an electric field generated by a pair of coiled electrodes 108a, 108b of the AC-driven MOS capacitor 104 is applied onto the target skin surface to facilitate skin growth and wound healing. At Step 126, light with one or more selectable wavelengths is emitted on the target skm surface to facilitate pain relief and enhanced wound healing. The light is generated by a light-emitting electroluminescence layer 106 of the AC-driven MOS capacitor 104 upon applying the electric field. At Step 128, the one or more selectable wavelengths and / or an energy level of the light are tuned by a gate layer 112 of the AC-driven MOS capacitor 104. The light-emitting electroluminescence layer 106 arranged coplanar with and between the pair of coiled electrodes 108a, 108b, a dielectric layer 110, and the gate layer 112 are arranged to form a stacked configuration of the AC-driven MOS capacitor 104.

[0043] In other words, the method 120 may be carried out by the wearable device 100 of FIG. 1A. The multimodal therapy may include a combination of electrotherapy and phototherapy. More specifically, the wearable device 100 is capable of providing optical and electrical radiation to a localized area of a patient for accelerating wound healing and pain relief, phototherapy, and aesthetic applications. The combination of electrotherapy (to facilitate skin growth and wound healing) and phototherapy (for pain relief and accelerated healing) targets multiple biological pathways. Phototherapy works at the cellular level, converting light energy into chemical energy (adenosine triphosphate, ATP) to improve cellular metabolism. The wearable device 100 or patch offers adjustable therapeutic protocols, thereby providing multimodal therapy, which may be tuned to meet individual patient needs, allowing for personalized treatment plans for different medical conditions, adding a level of customization that is not found in most existing therapy devices. In other words, the wearable device 100 provides both electrotherapy and phototherapy with the ability to tune the output energy for each modality.

[0044] The one or more selectable wavelengths of the light may be dependent on materials used for the light-emitting electroluminescence layer 106 and range from 430 nm to 980 nm. The shift in emitted wavelengths may be driven by the interaction of low-energy emitting molecules and high-energy emitting molecules, which is an innovative mechanism for wavelength control.

[0045] In various embodiments, the method 120 may further include varying an AC signal fed to the pair of electrodes 108a, 108b to adjust strength of the electric field.

[0046] In various embodiments, the method 120 may further include delivering, via a hydrogel layer upon contact with the subject, one or more therapeutic agents to the target skin surface. The hydrogel layer may be disposed over and encapsulating at least part of the light-emitting electroluminescence layer 106 and the pair of coiled electrodes 108a, 108b.

[0047] While the method described above is illustrated and described as a series of steps or events, it will be appreciated that any ordering of such steps or events are not to be interpreted in a limiting sense. For example, some steps may occur in different orders and / or concurrently with other steps or events apart from those illustrated and / or described herein. In addition, not all illustrated steps may be required to implement one or moreaspects or embodiments described herein. Also, one or more of the steps depicted herein may be carried out in one or more separate acts and / or phases.

[0048] Examples of the wearable device 100 and the non-invasive method 120 for performing tunable multimodal therapy on a subject will be described in more details as follow.

[0049] As discussed above, the wearable device 100 or interchangeably referred to as a wearable multimodal therapy patch is thin, flexible, printable, and features customizable therapeutic protocols to suit individual patient needs. As the patch may be printed at a low cost, this would provide an economical option for patients requiring continuous care. The patch includes several flexible layers, allowing high flexibility to conform to curves of the subject body. This is particularly beneficial for home use since the patch may be designed to fit comfortably on various parts of the body without impeding movement. The patch is based on LEC technology, which operates on the principle of EL. Unlike traditional lightemitting devices e.g. LEDs, which generally focus on phototherapy, LEC includes a thin, flexible layer of organic / inorganic materials that emit light when an electric field is applied. The structure of LEC for the patch is specially designed as an AC-driven MOS capacitor (e.g. 104 ofFIG. 1A).

[0050] The use of the AC-driven MOS capacitor 104 in a wearable form to simultaneously emit light and generate an electric field for therapeutic purposes is unique. The patch operates with high efficiency, consuming minimal (or low) power, and does not generate heat, ensuring patient safety and comfort during use. Thus, the energy-efficient nature of the patch, driven by the LEC structure, makes it suitable for continuous, long-term use without consuming excessive power. This is a significant advantage over traditional therapies that require more energy-intensive components such as lasers or LEDs.

[0051] Further, unlike conventional LED-based systems, the LEC approach allows for precise control over the wavelength and energy of the emitted light without needing different LEDs for each wavelength. This tunable light output makes the device more versatile, as the patch may be adjusted to target specific medical conditions (e.g. different wavelengths for wound healing, pain relief, or phototherapy).

[0052] FIG. 2A shows a schematic cross-sectional view illustrating the structure of a wearable multimodal therapy LEC-based patch 200, according to an example. FIG. 2Bshows a top view of the wearable multimodal therapy LEC-based patch 200, as seen from a directional arrow 215. The wearable multimodal therapy LEC-based patch 200 may include the same or like elements or components as those of the wearable device 100 of FIG. 1 A, and as such, the same ending numerals are assigned and the like elements may be as described in the context of the wearable device 100 of FIG. 1A, and therefore the corresponding descriptions are omitted here.

[0053] As shown in FIGS. 2A and 2B, there is provided a biocompatible adhesive microporous fabric tape 207 forming a support base for the wearable multimodal therapy LEC-based patch 200, and a photoelectric emitting unit formed by an AC-driven MOS capacitor 204 sandwiched between protective layers 202, 202’ of thermoplastic polyurethane (TPU). The AC-driven MOS capacitor 204 includes a light-emitting EL layer 206 as the semiconductor, parallel coiled interdigitated electrodes 208a, 208b (at least part of which serve as the top source contact), and a silver paste layer 212 (e.g. described in similar context with the gate layer 112 of FIG. 1 A) serving as the back gate along with a dielectric layer 210.

[0054] The light-emitting EL layer 206 includes an ultrathin low-energy emitting molecule layer 203b, e.g. green (bis [2-(2-pyridinyl-N)phenyl-C] (acetylacet onate)iridium(III), Trppy2acac), and blue (4,4’-bis[4-(diphenylamino) styryl]-biphenyl, BDAVBi), and a host layer of high-energy emitting molecules 203a, e.g. (4,4’-bis(N-carbazolyl)-l,l’-biphenyl, CBP), capable of producing selectable light wavelengths, including green, red, nearinfrared, and blue light when an electric field is applied.

[0055] The output light wavelength (or simply referred to as output wavelength) and energy (emission intensity) may be tunable by adjusting the frequency and / or voltage of the AC driving waveform 211 at the back gate 212 via the electrical connection 213b.

[0056] The output light wavelength may be tuned within the range of 430 to 910 nm, depending on the EL materials used, as listed in Table 1 below.

[0057] Table 1 - Emitting wavelengths vs EL materials1NORGANK ' 1NORGANK ’ AND DOMINANT ORGANK ' INORGANIC ' EL MA TER1AL (HOST: LIG1ETWAVELENGTHS DOPANT) EMITTED EROM El. SOURCE CBP:BDAVBi 490 nm and 650 nmCBP CzDBA 564 nm to 650 nm CBP:Irppy2acac 540 nm to 650 nm ZnS:Tm (Thulium) 480 nm and 800 nm ZnS : Nd(N eodymium) 890 nm ZnS:Er (Erbium) 550, 660 and 980 nm ZnS:Mn 580 nm (yellow) SrS:Cu 475 nm (green / blue) (SrS:Cu,Ag) (430 nm) (blue) SrS:Ce 510-550 nm double peaked Eu(TTFA)3(phen):PBD:PVK 612 nm (red) Yb(TPP)acac:MEH-PPV 977 nm

[0058] While the example in FIG. 2 A shows the electrodes 208a, 208b having a height that is substantially similar to a height of the light-emitting EL layer 206, it should be appreciated that it is possible for a different example to include electrodes 208a, 208b and a light-emitting EL layer 206 having different heights (thicknesses). In other words, the electrodes 208a, 208b and the light-emitting electroluminescence layer 206 may have identical or different thicknesses depending on design requirements.

[0059] FIG. 4 shows an output light wavelength spectrum 401 with the frequency of 10 kHz, according to an example. FIG 5 shows an output light wavelength spectrum 501 with the frequency of 1 MHz, according to an example As shown in FIG. 4, when a low-frequency AC voltage is applied, the rate of charge injection is low enough that all generated excitons in the emissive layer are absorbed by the low-energy emitting molecules. As the frequency increases (see Fig. 5), the charge injection rate rises, leading to a higher exciton density that exceeds the capacity of the low-energy emitters. The excess excitons are then absorbed by the higher-energy molecules, where they recombine. As high-energy photon emission overtakes low-energy photon emission, a distinct shift in the emitted wavelength shift occurs.

[0060] As discussed above, the light wavelengths (red, blue, near-infrared, and green) may be precisely controlled by adjusting the AC driving frequency and voltage. Meanwhile, the electric field strength may be tuned by modifying the supply voltage to the coiled electrodes208a, 208b. The combined optical and electrical energy may be tailored to meet specific therapeutic needs.

[0061] The coiled electrodes 208a, 208b are responsible for producing electric field to the treatment area which aids wound healing by mimicking the body’s natural electrical signals that promote cell migration and proliferation. FIG. 3 shows a schematic representation illustrating a finite element analysis simulation of the electric field distribution of the coiled electrodes 208a, 208b, according to an example. The strength of the electrical field emitted by the electrodes 208a, 208b may be adjusted or tunable by varying the supply voltage 209, 211 coupled to the top source contact via the electrical connections 213a, 213b, 213c. In other words, the electric field strength may be adjusted by varying the applied voltage 209 to the electrodes 208a, 208b.

[0062] The output of electric field and light may provide the combined therapeutic effects of electrotherapy and phototherapy. The combination of phototherapy and electrotherapy enhances the overall therapeutic effect by targeting multiple biological pathways simultaneously. Integrating electrotherapy (via adjustable electric fields generated by coiled electrodes 208a, 208b) and phototherapy (via tunable light emission) into the single wearable patch 200 is a unique combination that offer a synergistic effect, enhancing therapeutic outcomes and healing efficiency. Such combination / integration is not typical in conventional therapies that are delivered separately and carried out by distinct devices and treatment processes. Thus, the AC-driven MOS capacitor 204 simultaneously enables electroluminescence and electric field generation within a single integrated structure, thereby providing co-located multimodal therapy without requiring separate devices. Electrotherapy is able to direct the migration of many epithelial cellular for efficient wound healing. Electrical field may imitate the natural wound-healing mechanism of the endogenous electric field to facilitate skin growth Phototherapy is significantly efficient in relieving pain and improving wound healing. From cellular level, photon energy may be absorbed by the mitochondria and cell membranes and may be converted to chemical kinetic energy and increased oxidative metabolism to produce more ATPs.

[0063] The tunability of both phototherapy and electrotherapy energy levels makes the patch 200 highly customizable for individual patients. By adjusting the light wavelength (based on patient needs such as wound healing, pain relief, or aesthetic treatment) and theintensity of the electric field (to mimic the body’s natural electrical signals), the patch 200 may provide the synergistic effect that enhances healing. This adaptive, patient-specific approach allows for personalized treatments that may be fine-tuned based on the patient’s condition, stage of healing, or type of tissue being treated

[0064] A hydrogel layer 205 encapsulates the photoelectric emitting unit, providing additional benefits of moisture retention, protection against external contaminants, and enhanced tissue adherence. The hydrogel layer 205 may deliver therapeutic agents directly to the treatment area, further promoting wound healing and ensuring the patch 200 remains securely in place without interfering with the patient’s daily routine. As such, secure placement of the patch 200 may be achieved to allow for continuous therapy even during daily activities of the patient.

[0065] The combination of phototherapy, electrotherapy, and the properties of the hydrogel (provided by the hydrogel layer 205) provides a multifunctional therapeutic platform that not only enhances the overall therapeutic effect by targeting multiple biological pathways simultaneously, but also ensures optimal conditions for healing and pain relief. In other words, such combination enhances therapeutic capabilities beyond just light and electric stimulations. By the multifunctional hydrogel integration in the patch 200, both the functionality and comfort / usability for patients may be significantly improved.

[0066] The patch 200 is scalable to cover large areas and provides uniform illumination across the treated area, ensuring consistent therapeutic effects. The patch 200 supports portable treatment, allowing patients to receive therapy while on the move, thereby enhancing convenience and compliance. The patch 200 may be adapted into several formats, such as adhesive bandages, facial masks, or wound dressings, making it versatile for various medical and cosmetic applications.

[0067] Various medical and cosmetic applications may include the following• Wound Healing:The patch 200 may be used in clinical and home settings to accelerate wound healing, particularly for chronic wounds such as diabetic ulcers, pressure sores, and surgical wounds. The combination of phototherapy and electrotherapy may enhance cell proliferation, tissue regeneration, and reduce healing time.• Pain Relief:The patch 200 may provide localized pain relief through electrotherapy, which stimulates nerves and muscles, and phototherapy, which reduces inflammation. It may be used for conditions like arthritis, musculoskeletal pain, and neuropathic pain.• Aesthetic Applications:The patch 200 may be used in cosmetic treatments to improve skin texture, reduce wrinkles, and promote collagen production. Its flexibility allows it to conform to different facial contours, making it ideal for at-home skincare routines.• Chronic Venous Insufficiency Treatment:The patch 200 may be applied to improve blood circulation in patients with chronic venous insufficiency, reducing symptoms such as swelling, pain, and venous ulcers.• Sports Recovery:Athletes may use the patch 200 for muscle recovery post-exercise. The combined therapies may reduce muscle soreness, inflammation, and accelerate recovery from injuries.• Physical Therapy and Rehabilitation:The patch 200 may be integrated into physical therapy programs to assist in the rehabilitation of injured muscles, tendons, and ligaments, enhancing the effectiveness of physical therapy exercises• Post-Surgical Recovery:The patch 200 may be used post-surgery to reduce pain, prevent infection, and accelerate wound healing, leading to faster recovery times and reduced hospital stays.• Chronic Disease Management:Patients with chronic conditions like diabetes, venous diseases, or arthritis may use the patch 200 as part of a long-term management plan to reduce symptoms, prevent complications, and maintain their quality of life.• Veterinary Medicine:The patch 200 may be adapted for use in veterinary applications, helping to treat wounds, manage pain, and improve healing in animals.• Military and Emergency Medicine:The patch 200 may be used in military or emergency medical situations for rapid wound care, pain management, and recovery in the field, providing immediate therapeutic benefits in austere environments.[0068J While the invention has been particularly shown and described with reference to specific embodiments, it should be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. The scope of the invention is thus indicated by the appended claims and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced.

Claims

CLAIMS1. A wearable device for performing tunable multimodal therapy on a subject, the wearable device comprising:a protective layer; andan alternative current (AC)-driven metal oxide semiconductor (MOS) capacitor disposed on the protective layer,wherein the AC-driven MOS capacitor comprises:a light-emitting electroluminescence layer adapted to generate light with one or more selectable wavelengths upon applying an electric field;a pair of coiled electrodes configured to receive an adjustable AC signal to generate the electric field, the light-emitting electroluminescence layer arranged coplanar with and between the pair of coiled electrodes;a gate layer configured to receive the adjustable AC signal for tuning the one or more selectable wavelengths and / or an energy level of the light generated by the light-emitting electroluminescence layer; anda dielectric layer arranged between the light-emitting electroluminescence layer and the gate layer.

2. The wearable device as claimed in claim 1, wherein the light-emitting electroluminescence layer comprises an ultrathin layer of low-energy emitting molecules and a host layer of high-energy emitting molecules.

3. The wearable device as claimed in claim 2, wherein the low-energy emitting molecules comprise an inorganic material.

4. The wearable device as claimed in claim 2 or 3, wherein the low-energy emitting molecules comprise:4,4’-bis(N-carbazolyl)-l,l’-biphenyl;9,10-bis(4-(9H-carbazol-9-yl)-2,6-dimethylphenyl)-9,10-diboraanthracene, bis [2-(2-pyridiny 1-N)pheny 1- C] (acety lacetonate) iridium(III) ;thulium;neodymium;erbium;magnesium;copper;copper-silver alloy,cerium;poly [2-methoxy-5-(2’-ethylhexyloxy)-l,4-phenylene vinylene];poly(N-vinylcarbazole); ora blend of 2-tert-butylphenyl-5-biphenyl-l,3,4-oxadiazol with poly(N- vinylcarbazole).

5. The wearable device as claimed in any one of claims 2 to 4, wherein the high-energy emitting molecules comprise an organic material or an inorganic material.

6. The wearable device as claimed in any one of claims 2 to 5, wherein the high-energy emitting molecules comprise:4,4'-Bis (N-carbazolyl)-! ,1 '-biphenyl;zinc sulfide;strontium sulfide,Eu(TTFA)3(phen) where TTFA is thenoyltrifluoroacetone monoanion and phen is 1,10-phenanthroline; orYb(TPP)acac where TTP is tetraphenylporphyrin.

7. The wearable device as claimed in any one of claims 1 to 6, wherein the pair of coiled electrodes comprises interdigital coiled electrodes.

8. The wearable device as claimed in any one of claims 1 to 7, wherein the pair of coiled electrodes comprises gold, platinum, or palladium.

9. The wearable device as claimed in any one of claims 1 to 8, wherein the gate layer comprises silver, gold, aluminum, copper, indium tin oxide, graphene, a conductive polymer, or any combinations thereof.

10. The wearable device as claimed in any one of claims 1 to 9, further comprising a further protective layer, wherein the AC-driven MOS capacitor is arranged between the protective layer and the further protective layer.

11. The wearable device as claimed in claim 10, wherein each of the protective layer and the further protective layer comprises thermoplastic polyurethane.

12. The wearable device as claimed in any one of claims 1 to 11, further comprising a hydrogel layer disposed over and encapsulating at least part of the light-emitting electroluminescence layer and the pair of coiled electrodes.

13. The wearable device as claimed in claim 12, wherein the hydrogel layer is configured to deliver one or more therapeutic agents to the subject upon contact with the subject.

14. The wearable device as claimed in any one of claims 1 to 13, further comprising a flexible supporting base coupled to the protective layer.

15. The wearable device as claimed in claim 14, wherein the flexible supporting base comprises a fabric tape configured to adhere the wearable device to the subject.

16. The wearable device as claimed in any one of claims 1 to 15, wherein the AC- driven MOS capacitor is fabricated via film patterning and printing techniques.

17. A non-invasive method for performing tunable multimodal therapy on a subject, the method comprising:placing a wearable device on a target skin surface of the subject, wherein the wearable device comprises an AC-driven MOS capacitor;applying an electric field generated by a pair of coiled electrodes of the AC-driven MOS capacitor onto the target skin surface to facilitate skin growth and wound healing;emitting light with one or more selectable wavelengths on the target skin surface to facilitate pain relief and enhanced wound healing, wherein the light is generated by a lightemitting electroluminescence layer of the AC-driven MOS capacitor upon applying the electric field; andtuning, by a gate layer of the AC-driven MOS capacitor, the one or more selectable wavelengths and / or an energy level of the light,wherein the light-emitting electroluminescence layer arranged coplanar with and between the pair of coiled electrodes, a dielectric layer, and the gate layer are arranged to form a stacked configuration of the AC-driven MOS capacitor.

18. The non-invasive method as claimed in claim 17, wherein the one or more selectable wavelengths of the light are dependent on materials used for the light-emitting electroluminescence layer and range from 430 nm to 980 nm.

19. The non-invasive method as claimed in claim 17 or 18, further comprising varying an AC signal fed to the pair of electrodes to adjust strength of the electric field.

20. The non-invasive method as claimed in any one of claims 17 to 19, further comprising delivering, via a hydrogel layer upon contact with the subject, one or more therapeutic agents to the target skin surface, wherein the hydrogel layer is disposed over and encapsulating at least part of the light-emitting electroluminescence layer and the pair of coiled electrodes.

21. The non-invasive method as claimed in any one of claims 17 to 20, wherein the multimodal therapy comprises a combination of electrotherapy and phototherapy.

22. The non-invasive method as claimed in any one of claims 17 to 21, being carried out by a wearable device as claimed in any one of claims 1 to 16.